tiprankstipranks
Urogen Pharma (URGN)
NASDAQ:URGN

Urogen Pharma (URGN) Stock Investors

427 Followers
Based on 746,050 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold URGN
On average, investors allocate 0.00% of their portfolios to URGN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,050 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding URGN

0.2%
Last 7
Days
3.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding URGN, out of 746,050 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

URGN Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.34%
$13.07
Opened
3.62%
$14.37
Based on the activity of 14,161 investors who made their portfolios public
The table shows changes in URGN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

URGN Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.81%
-0.93%
-1.56%
33.23B
Consumer Cyclical
Coherus Biosciences
2.54%
-1.95%
-5.06%
190.44M
Healthcare
Bristol-Myers Squibb
3.16%
-1.04%
+1.58%
82.02B
Healthcare
Merck & Company
3.91%
+0.78%
+3.63%
323.59B
Healthcare
Trade Desk
4.66%
+0.48%
+2.26%
48.66B
Technology
Baidu
5.26%
+4.60%
+13.51%
36.99B
Communication Services
Applied Materials
4.69%
+1.36%
+6.24%
201.53B
Technology
PDD Holdings
5.05%
+0.76%
+3.65%
189.22B
Consumer Cyclical
Lockheed Martin
4.91%
-0.13%
+1.23%
111.27B
Industrials
Raytheon Technologies
4.00%
-0.96%
-0.64%
134.65B
Industrials
Based on the activity of 746,050 active portfolios
Open your Smart Portfolio

URGN Investor Analysis

URGN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.3%
of URGN holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
URGN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
48.5%
of URGN holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
URGN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
41.2%
of URGN holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of URGN stock investors
See who invests in URGN according to age group and performance.

FAQ

How many retail Investors hold URGN?
<0.1% of TipRanks' retail investors hold URGN in their portfolios.
    What is URGN Investor Sentiment?
    URGN’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of URGN in the last 7 days?
      ▼ 0.2% of TipRanks' retail investors changed their holding of URGN in the last 7 days.
        What percentage of retail investors changed their holding of URGN in the last 30 days?
        ▲ 3.9% of TipRanks' retail investors changed their holding of URGN in the last 30 days.
          What is the average age of retail investors who hold URGN?
          The average age of URGN Holders is between 35–55.
            What other stocks have URGN investors also bought?
            URGN Investors also bought DKNG, CHRS, BMY, MRK, TTD, BIDU, AMAT, PDD, LMT, RTX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BSXBoston Scientific
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              HAEHaemonetics
              INSMInsmed
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis